Interpace Biosciences Inc (NASDAQ:IDXG)

4.35
Delayed Data
As of 3:59pm ET
 +0.05 / +1.16%
Today’s Change
2.57
Today|||52-Week Range
11.00
+38.54%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Interpace Biosciences Inc have a median target of 9.40, with a high estimate of 12.00 and a low estimate of 6.00. The median estimate represents a +116.09% increase from the last price of 4.35.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Interpace Biosciences Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.11
Sales
$8.8M
Reporting Date
Mar 31

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 27.23%
 
 
 
 
 
 
Growthannually 22.36%
 
 
 
 
 
 

Sales

Growthquarterly 7.15%
 
 
 
 
 
 
Growthannually 30.20%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.